Bonifacio, Rosalyn L.
HRN: 10-58-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
AMPICILLIN 1GM (VIAL)
09/14/2022
09/21/2022
IV
2grams
Q6
Premature Rupture Of Membranes; TMSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes